Literature DB >> 21844298

S100A4 deficiency is associated with efficient bacterial clearance and protects against joint destruction during Staphylococcal infection.

Li Bian1, Paulina Strzyz, Ing-Marie Jonsson, Malin Erlandsson, Annelie Hellvard, Mikael Brisslert, Claes Ohlsson, Noona Ambartsumian, Mariam Grigorian, Maria Bokarewa.   

Abstract

BACKGROUND: Efficient host defense mechanisms are crucial for survival in sepsis and septic arthritis. S100 proteins are reported to have proinflammatory and bactericidal properties. The aim of this study was to investigate the role of S100A4 in staphylococcal arthritis.
METHODS: S100A4 knockout mice (S100A4KO) and wild-type counterparts (WT) were intravenously and intra-articularly challenged with Staphylococcus aureus strain LS-1. Clinical and morphological signs of arthritis and sepsis, phagocytosis, bone mineral density (BMD), and bone metabolism were then monitored in S100A4 and WT mice.
RESULTS: S100A4KO mice had a lower bacterial load in the kidneys than WT mice (P < .05) but developed more severe clinical signs of arthritis (P < .001) and had higher levels of interleukin 6 and L-selectin (P = .002). S100A4KO mice had fewer morphological signs of synovitis and cartilage/bone destruction following intra-articular instillation of bacteria. S100A4KO mice were protected from loss of BMD and had lower levels of RANKL, MMP3, and MMP9 (P < .05). S100A4 was not bactericidal in vitro.
CONCLUSIONS: In staphylococcal infection, S100A4 regulates bacterial clearance as well as systemic and local inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844298     DOI: 10.1093/infdis/jir369

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.

Authors:  Barbora Šumová; Lucie Andrés Cerezo; Lenka Szczuková; Lucie Nekvindová; Michal Uher; Hana Hulejová; Radka Moravcová; Mariam Grigorian; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt; Jakub Závada
Journal:  Rheumatol Int       Date:  2018-11-03       Impact factor: 2.631

2.  A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.

Authors:  Sören Bruhn; Yu Fang; Fredrik Barrenäs; Mika Gustafsson; Huan Zhang; Aelita Konstantinell; Andrea Krönke; Birte Sönnichsen; Anne Bresnick; Natalya Dulyaninova; Hui Wang; Yelin Zhao; Jörg Klingelhöfer; Noona Ambartsumian; Mette K Beck; Colm Nestor; Elsa Bona; Zou Xiang; Mikael Benson
Journal:  Sci Transl Med       Date:  2014-01-08       Impact factor: 17.956

3.  S100A4 upregulation suppresses tissue ossification and enhances matrix degradation in experimental periodontitis models.

Authors:  Min Zhou; Zhuo-quan Li; Zuo-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2015-10-26       Impact factor: 6.150

Review 4.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

5.  S100A4 contributes to colitis development by increasing the adherence of Citrobacter rodentium in intestinal epithelial cells.

Authors:  Jinhua Zhang; Ying Jiao; Shasha Hou; Tian Tian; Qi Yuan; Huaijie Hao; Zhenlong Wu; Xuexiang Bao
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

Review 6.  Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.

Authors:  Philipp Licht; Volker Mailänder
Journal:  Cells       Date:  2022-01-19       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.